NEW WELLLINK
871634
VIBO
871245
MTD
835579
4
REFORMER
833030
5
Hunan Sundy Science And Technology
300515
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.